tiprankstipranks
Vertex Pharmaceuticals price target raised to $486 from $480 at Scotiabank
PremiumThe FlyVertex Pharmaceuticals price target raised to $486 from $480 at Scotiabank
16d ago
Vertex Pharmaceuticals price target raised to $560 from $502 at Bernstein
Premium
The Fly
Vertex Pharmaceuticals price target raised to $560 from $502 at Bernstein
16d ago
Vertex Pharmaceuticals price target raised to $476 from $473 at Morgan Stanley
Premium
The Fly
Vertex Pharmaceuticals price target raised to $476 from $473 at Morgan Stanley
16d ago
Vertex Pharmaceuticals reports Q3 adjusted EPS $4.38, consensus $4.14
PremiumThe FlyVertex Pharmaceuticals reports Q3 adjusted EPS $4.38, consensus $4.14
17d ago
Notable companies reporting after market close
Premium
The Fly
Notable companies reporting after market close
17d ago
Options Volatility and Implied Earnings Moves Today, November 04, 2024
Premium
Market News
Options Volatility and Implied Earnings Moves Today, November 04, 2024
17d ago
Vertex Pharmaceuticals initiated with a Sector Perform at Scotiabank
PremiumThe FlyVertex Pharmaceuticals initiated with a Sector Perform at Scotiabank
1M ago
Vertex Pharmaceuticals price target lowered to $541 from $550 at BofA
Premium
The Fly
Vertex Pharmaceuticals price target lowered to $541 from $550 at BofA
1M ago
Vertex Pharmaceuticals reinstated with a Market Perform at Raymond James
Premium
The Fly
Vertex Pharmaceuticals reinstated with a Market Perform at Raymond James
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100